KIRAN MAZUMDAR SHAW

THE BIOCON STORY

Biocon Info.
Company's Slogan: Driving Innovation Delivering
Affordability 
Company's Mission: To be an integrated biotechnology
enterprise of global distinction. 
Company Type: Private Sector
 Industry: Pharmaceuticals 
Number of Employees -4478
 Dr. Kiran M. Shaw

aster B.Sc
rewer Born on
Zoology
rom from 23
allarat March
Bangalo
iversit 1953 in
y in re
Bangalo
universi
elbour
re
e 1975ty 1973
The journey begins…
Started Biocon India from her garage.

Initial Capital Rs/- 10,000.

Started extracting enzyme (papain) from papaya &

isinglass (fish moss)
Early Hurdles…

Financing regular operations

Approached financial institutions, but turned down,
coz:
 Biotechnology is a new word
 No assets for company
 Woman entrepreneur is a rare word

Recruiting staff
Break through…..
1979 -Biocon is the first Indian company to manufacture and
export enzymes to USA and Europe
1989-Unilever plc. acquires Biocon Biochemicals Ltd. in
Ireland and merges it with its subsidiary, Quest International
 Biocon is the first Indian biotech company to receive US
funding for proprietary technologies
1990 Biocon scales up its in-house research programme,
based on a proprietary solid substrate fermentation
technology, from pilot to plant level
1993 Biocon's R&D and manufacturing facilities receive ISO
9001 certification from RWTUV, Germany
Cont..
1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom
research Company (CRC) to address the growing need for outsourced R&D
in the pharmaceutical sector.Its India's first custom  research company
in drug discovery.
1997 Biocon spearheads initiatives in human healthcare through a
dedicated manufacturing facility
1998Unilever inks a deal with ICI to sell its specialty chemicals division of
which Quest International is a part. Unilever agrees to sell its shareholding
in Biocon to the Indian promoters. Biocon becomes an independent entity
2000 Biocon commissions its first fully automated submerged fermentation
plant to produce specialty pharmaceuticals.Biocon establishes Clinigene,
India's first Clinical Research Organisation (CRO) to pursue clinical
research and development
Cont..
2001 Biocon becomes the first Indian company to be approved by US FDA
for the manufacture of lovastatin, a cholesterol-lowering molecule Biocon's
proprietary bioreactor, PlaFractor™ is granted a US 2001 and world-wide
patent
2002 Clinigene's clinical laboratory is the first in India to receive CAP
accreditation
2003 Biocon is the first company worldwide to develop human insulin on a
Pichia expression system
2004 Biocon creates a buzz in the stock market in March 2004 with its
hugely successful IPO. Day 1 on the bourses closes with a market value of
$1.11 billion, making Biocon only the second Indian company to cross the $1
billion mark on the first day of listing.
Biocon Limited announces the launch of INSUGENR, the new generation
bio-insulin , manufactured in Asia's largest human insulin plant.
Cont..
2006 Biocon inaugurates Biocon Biopharmaceuticals, India's largest
multi-product Biologics facility at Biocon Park
Biocon launches India's first anti-cancer drug BIOMAb EGFR™.
2007 Biocon and Abu Dhabi based pharmaceutical company
Neopharma sign an MOU to establish a JV to manufacture and market a
range of biopharmaceuticals for the GCC countries (Gulf Cooperation
Council). .
Biocon announces the launch of its Nephrology Division and a
comprehensive portfolio of renal therapy products.
2008 Biocon acquires a 70% stake in German pharmaceutical
company, AxiCorp GmbH for a consideration of €30 Million
Biocon and Abraxis Bioscience launch ABRAXANE in India for
treatment of Breast Cancer.
Cont..
Biocon is ranked among the top 20 global
biotechnology companies (Med Ad News). Biocon is
the 7th largest biotech employer in the world (Med Ad
News).
The process
 Products and services
Biopharmaceuticals Licensing
Contract manufacturing Research
services
●
Anti-Diabetic Agents
●
Anti-Hypertensive Agents
●
Anti-Inflammatory Agents
●
Antioxidants
●
Cardiovascular Agents
●
Digestive Aid Enzymes
●
Haemostatic Agents
●
Hepatoprotective Agents
●
Immunosuppressants
●
Nutraceuticals 
Financials
Strategies…
No commodity production in beginning due to lack of infrastructure
Diversification rather than expansion
Formed Helix (antibiotic prod.)
Formed Syngene, Clinigene (R&D in fermentation)
Biocon Quest (BQ) to produce these products in mass
Strategic alliances with 20 companies around globe. Eg AXICORP , DEAKIN
UNIVERSITY
Fully integrated business model
Enzymes produced & sold as industrial intermediaries
Customer (staying with buyer’s processing line helping them obtain desired result
from the enzyme)
Created an image of a reliable company able to give highly competent technical
products & support
Also custom based products at any level.
Competitors..
 Cadila Healthcare
Divi's Lab   
Lupin Ltd.
 Glenmark Pharma
 GlaxoSmithKline Phar
 Aurobindo Pharma
 Dr. Reddy's Labs   
Fortis Healthcare
Sun Pharma.  
 Cipla (Sensex)
Future & long term developments
 Mega-marketing deal with Pfizer
to drive growth in the short
term:In October, 2010, Biocon
signed a mega-marketing deal
with the world’s largest Pharma
company.
 Focus on emerging countries
 Oral insulin the next
blockbuster opportunity
 CSR- Biocon Foundation 
 Arogya Raksha Yojana (ARY) Healthcare Initiatives
 Primary Health Education & Implementation
 Infrastructure: constructing school buildings
(including a performance stage, flooring,
classrooms),creches, sanitary facilities and water
supply connections.
Under phase I of the sanitation program, 700 toilets
have been built in Huskur.
Recognition:
Kiran Mazumdar-Shaw features on the Forbes list of ‘The World’s 100
Most Powerful Women
Awarded the prestigious ‘Nikkei Asia Prize’ 2009 for regional growth.
Padma Bhushan (2005)
The Economic Times Business Woman of the Year Award (2004)
Ernst & Young Entrepreneur of the Year Award in Healthcare & Life
Sciences (2002) Padma Shri (1989)
 Outstanding Young Person Award by Jaycees (1987) Rotary award for
the Best Model Employer (1983)
Gold for Best Woman Entrepreneur , Institute of Marketing
Management (1982)
SUCCESS MANTRA – MS. SHAW
Determination
Willingness to take risk
Talented team
Spirit of Adventure
Thank you….

Presented by
Manali Tongia